close 73% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 73% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

1,031.24

-1.05%↓

JNJ

205.45

+0.09%↑

ABBV

230.21

+2.52%↑

UNH

340.43

+4.83%↑

AZN

90.83

+0.56%↑

LLY

1,031.24

-1.05%↓

JNJ

205.45

+0.09%↑

ABBV

230.21

+2.52%↑

UNH

340.43

+4.83%↑

AZN

90.83

+0.56%↑

LLY

1,031.24

-1.05%↓

JNJ

205.45

+0.09%↑

ABBV

230.21

+2.52%↑

UNH

340.43

+4.83%↑

AZN

90.83

+0.56%↑

LLY

1,031.24

-1.05%↓

JNJ

205.45

+0.09%↑

ABBV

230.21

+2.52%↑

UNH

340.43

+4.83%↑

AZN

90.83

+0.56%↑

LLY

1,031.24

-1.05%↓

JNJ

205.45

+0.09%↑

ABBV

230.21

+2.52%↑

UNH

340.43

+4.83%↑

AZN

90.83

+0.56%↑

Strona główna・Stock List・Seres Therapeutics Inc
Search

Seres Therapeutics Inc

Closed

SectorHealthcare

17.1 2.89

Buy

Price update 3 gru 2025, 20:58 UTC

BuySell

Overview

Share price change

24h

Current

Min

16.47

Max

17.73

Key metrics

By Trading Economics

Income

28M

8.2M

Sales

351K

351K

P/E

Sector Avg

19.705

80.03

EPS

0.94

Profit margin

2,337.322

Employees

103

EBITDA

28M

9.3M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+26.87% upside

Market Stats

By TradingEconomics

Market Cap

23M

157M

Previous open

14.21

Previous close

17.1

News Sentiment

By Acuity

17%

83%

30 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

N/A / 9.31 Support & Resistance

Seres Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

2 gru 2025, 17:29 UTC

Major Market Movers
Acquisitions, Mergers, Takeovers

Laurentian Bank Shares Hit Two-Year High on Plans for Break-Up, Takeover

DJ

Read

2 gru 2025, 16:21 UTC

Earnings

Scotiabank Aiming for Earnings Growth After Capital Markets Buoy Results in Latest Quarter -- Update

DJ

Read

2 gru 2025, 16:18 UTC

Earnings

Correction to Scotiabank Quarterly Earnings Buoyed Article

DJ

Read

2 gru 2025, 23:53 UTC

Market Talk

Nikkei May Rise After Gains on Wall Street -- Market Talk

DJ

Read

2 gru 2025, 22:48 UTC

Earnings

Marvell's Stock Soars On Data Center Forecast -- Barrons.com

DJ

Read

2 gru 2025, 22:12 UTC

Market Talk

Australian 3Q GDP To Show Modest Recovery In Play -- Market Talk

DJ

Read

2 gru 2025, 22:03 UTC

Market Talk

Minerals 260's Resource Upgrade Looks Impressive -- Market Talk

DJ

Read

2 gru 2025, 22:00 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Read

2 gru 2025, 22:00 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

2 gru 2025, 22:00 UTC

Market Talk

Fletcher Building Loses Bull Due to Tame Housing-Market Recovery -- Market Talk

DJ

Read

2 gru 2025, 21:56 UTC

Earnings

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

DJ

Read

2 gru 2025, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

DJ

Read

2 gru 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Read

2 gru 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

DJ

Read

2 gru 2025, 21:44 UTC

Earnings

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

DJ

Read

2 gru 2025, 21:38 UTC

Market Talk

Sky Network TV Has Path to Grow Dividend by 33% -- Market Talk

DJ

Read

2 gru 2025, 21:19 UTC

Earnings

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

DJ

Read

2 gru 2025, 20:06 UTC

Market Talk

Oil Futures Fall Amid Russia-Ukraine Peace Talks -- Market Talk

DJ

Read

2 gru 2025, 19:55 UTC

Market Talk

Natural Gas Futures Fall Amid Uncertain Weather Forecasts -- Market Talk

DJ

Read

2 gru 2025, 19:53 UTC

Market Talk
Earnings

Global Equities Roundup: Market Talk

DJ

Read

2 gru 2025, 19:53 UTC

Market Talk
Earnings

Scotiabank ROE Target Viewed as Possibly Conservative -- Market Talk

DJ

Read

2 gru 2025, 19:24 UTC

Market Talk

Analysts Project Uptick in U.S. Ethanol Stocks -- Market Talk

DJ

Read

2 gru 2025, 19:06 UTC

Market Talk

Precious Metals Step Back After Silver Sets Record -- Market Talk

DJ

Read

2 gru 2025, 18:27 UTC

Acquisitions, Mergers, Takeovers

Kraken to Acquire Backed Finance AG

DJ

Read

2 gru 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Read

2 gru 2025, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

DJ

Read

2 gru 2025, 15:17 UTC

Market Talk

Natural Gas Extends Gains Amid Cold Weather -- Market Talk

DJ

Read

2 gru 2025, 14:47 UTC

Market Talk

BOE Likely to Cut Rates Further, Weakening Sterling -- Market Talk

DJ

Read

2 gru 2025, 14:38 UTC

Market Talk

Silver Steps Back From Record Levels -- Market Talk

DJ

Read

2 gru 2025, 14:31 UTC

Market Talk
Earnings

Scotiabank Strong Quarter Driven By Capital Markets Growth -- Market Talk

DJ

Read

Peer Comparison

Price change

Seres Therapeutics Inc Forecast

Price Target

By TipRanks

26.87% upside

12 Months Forecast

Average 22 USD  26.87%

High 22 USD

Low 22 USD

Based on 2 Wall Street analysts offering 12 month price targets forSeres Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Based on 2 analysts giving stock ratings to Seres Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

N/A / 9.31Support & Resistance

Short Term

Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Bearish Evidence

All events are bearish.

Long Term

Bearish Evidence

All events are bearish.

Sentiment

By Acuity

30 / 374 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

1,031.24

↓-1.05%

JNJ

Johnson and Johnson

205.45

↑ +0.09%

ABBV

AbbVie Inc

230.21

↑ +2.52%

UNH

UnitedHealth Group Inc

340.43

↑ +4.83%

AZN

AstraZeneca PLC ADR

90.83

↑ +0.56%
help-icon Live chat